Systemic Lupus Erythematosus Clinical Trials in Plantation, Florida

6 studies are recruiting for systemic lupus erythematosus in Plantation, Florida right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants

   This open-label, Phase I study will assess the safety and tolerability of surovatamig and characterise its PK and PD following subcutaneous administration to participants with RA or SLE.

   Stage

   Phase 1

   Ages

   18 to 65

   Site

   Research Site, Plantation, Florida

   Locations

   35 in total

   Run by

   AstraZeneca

   See if you can join NCT07201558 on ClinicalTrials.gov

2. A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)

   This study is open to adults with systemic lupus erythematosus (SLE). The purpose of this study is to find out whether a medicine called BI 3000202 helps people with SLE. The study tests different doses of BI 3000202 and aims to find the best dose for people with this condition. Participants are pu…

   Stage

   Phase 2

   Ages

   18 to 74

   Site

   Integral Rheumatology and Immunology Specialist, Plantation, Florida

   Locations

   140 in total

   Run by

   Boehringer Ingelheim

   See if you can join NCT07409181 on ClinicalTrials.gov

3. A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)

   Systemic lupus erythematosus (SLE) is a chronic, systemic autoimmune disease characterized by B cell hyperactivity. Rheumatoid Arthritis (RA) is a chronic inflammatory disease causing pain, stiffness, swelling and loss of joint function. The purpose of this study is to assess the pharmacokinetics, …

   Stage

   Phase 1

   Ages

   18 to 75

   Site

   Discovery Health Research Center /ID# 279691, Plantation, Florida

   Locations

   10 in total

   Run by

   AbbVie

   See if you can join NCT07607964 on ClinicalTrials.gov

4. A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

   The purpose of this study is to evaluate the ability of dapirolizumab pegol (DZP) as an add-on treatment to standard of care (SOC) medication to achieve clinically relevant long term improvement of moderate to severe disease activity.

   Stage

   Phase 3

   Ages

   16 and older

   Site

   Sl0044 50324, Plantation, Florida

   Locations

   242 in total

   Run by

   UCB Biopharma SRL

   See if you can join NCT06617325 on ClinicalTrials.gov

5. Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).

   The purpose of this study is to evaluate long-term safety and tolerability of ianalumab in participants with systemic lupus erythematosus who have previously completed the treatment period in one of the two SIRIUS-SLE core studies (CVAY736F12301 or CVAY736F12302).

   Stage

   Phase 3

   Ages

   12 to 100

   Site

   IRIS Research and Development, Plantation, Florida

   Locations

   143 in total

   Run by

   Novartis Pharmaceuticals

   See if you can join NCT06133972 on ClinicalTrials.gov

6. Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Diseases.

   This study will evaluate the safety and activity of AB-101 in combination with rituximab in B-cell associated autoimmune diseases where rituximab is currently FDA approved (e.g., Rheumatoid Arthritis (RA), Pemphigus Vulgaris (PV), Granulomatosis with polyangiitis (GPA)/microscopic polyangiitis (MPA…

   Stage

   Phase 1

   Ages

   18 and older

   Site

   IRIS Research and Development, LLC, Plantation, Florida

   Run by

   IRIS Research and Development, LLC

   See if you can join NCT06581562 on ClinicalTrials.gov